Open access
Aug 2026
Efferocytosis related KCTD12 is a clinico-immune target in lung adenocarcinoma
The efferocytosis-related risk signature provides a framework for prognostic and immune stratification, while KCTD12 represents a candidate biomarker associated with immune activation and clinical outcomes in immunotherapy-treated cohorts.
Shan Wen, Guan-Ya Cao, Yu Liu et al.
· Frontiers in Oncology · 0 citations